Bone Health Technologies

Bone Health Technologies has pioneered a novel, non-drug intervention for the large and underserved osteopenia market with its FDA-cleared Osteoboost wearable belt. The device uses targeted, low-intensity vibration therapy—technology inspired by NASA research—to stimulate bone-building cells and has demonstrated an over 80% reduction in spinal bone loss in a 12-month clinical trial. As a commercial-stage private company, it represents a significant innovation in women's musculoskeletal health, offering a preventive treatment option before osteoporosis develops. Its recognition as a TIME Best Invention of 2025 underscores its potential impact.

Targeted low-intensity mechanical vibration (inspired by NASA research) delivered via a wearable belt to stimulate bone-building cells and inhibit bone resorption.

Osteoboost has no direct competitors with FDA clearance for osteopenia. It competes indirectly with generic lifestyle advice (calcium, exercise), off-label use of whole-body vibration plates (not FDA-cleared for this indication), and pharmaceutical osteoporosis drugs, which are typically used for more severe disease. Its first-mover advantage and proprietary, targeted technology create a strong initial barrier to entry.